Breast-to-brain metastasis is exacerbated with chemotherapy through blood-cerebrospinal fluid barrier and induces Alzheimer's-like pathology

被引:3
作者
Saatian, B. [1 ,2 ]
Deshpande, K. [1 ,2 ]
Herrera, R. [1 ,2 ]
Sedighi, S. [1 ,2 ]
Eisenbarth, R. [1 ,2 ]
Iyer, M. [1 ]
Das, D. [1 ]
Julian, A. [1 ,2 ]
Martirosian, V. [1 ,2 ]
Lowman, A. [3 ]
LaViolette, P. [3 ]
Remsik, J.
Boire, A. [4 ]
Sankey, E. [5 ]
Fecci, P. E. [5 ]
Shiroishi, M. S. [2 ,6 ]
Chow, F. [1 ,2 ,7 ]
Hurth, K. [2 ,7 ,8 ]
Neman, J. [1 ,2 ,7 ,8 ,9 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Brain Tumor Ctr, Los Angeles, CA USA
[3] Med Coll Wisconsin, Dept Radiol & Biomed Engn, Milwaukee, WI USA
[4] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY USA
[5] Duke Univ, Sch Med, Dept Neurosurg, Durham, NC USA
[6] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA USA
[7] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[8] Univ Southern Calif, Keck Sch Med, Dept Neurosci & Physiol, Los Angeles, CA USA
[9] Univ Southern Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA USA
关键词
blood-cerebrospinal fluid barrier; brain metastasis; breast cancer; chemotherapy; CSF; tau; CANCER-TREATMENT; CHOROID-PLEXUS; TAU; ADJUVANT; SURVIVAL; NECROSIS; TUMOR; MMP-9;
D O I
10.1002/jnr.25249
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Control of breast-to-brain metastasis remains an urgent unmet clinical need. While chemotherapies are essential in reducing systemic tumor burden, they have been shown to promote non-brain metastatic invasiveness and drug-driven neurocognitive deficits through the formation of neurofibrillary tangles (NFT), independently. Now, in this study, we investigated the effect of chemotherapy on brain metastatic progression and promoting tumor-mediated NFT. Results show chemotherapies increase brain-barrier permeability and facilitate enhanced tumor infiltration, particularly through the blood-cerebrospinal fluid barrier (BCSFB). This is attributed to increased expression of matrix metalloproteinase 9 (MMP9) which, in turn, mediates loss of Claudin-6 within the choroid plexus cells of the BCSFB. Importantly, increased MMP9 activity in the choroid epithelium following chemotherapy results in cleavage and release of Tau from breast cancer cells. This cleaved Tau forms tumor-derived NFT that further destabilize the BCSFB. Our results underline for the first time the importance of the BCSFB as a vulnerable point of entry for brain-seeking tumor cells post-chemotherapy and indicate that tumor cells themselves contribute to Alzheimer's-like tauopathy. This study explores the relationship between cancer and neuroscience, focusing on how the nervous system impacts breast-to-brain metastasis (BBM). Chemotherapy's impact on tumor spread and cognitive function is explored, revealing that it increases brain-barrier permeability, aiding tumor infiltration through Matrix metalloproteinase 9 (MMP9) expression and Claudin-6 loss (A). Likewise, chemotherapy-induced MMP9 activity also contributes to tumor-derived neurofibrillary tangles leading to potential neurodegeneration (B). The study elucidates the vulnerability of the brain barrier and proposes a link between tumor cells and Alzheimer's-like tauopathy.image
引用
收藏
页码:1900 / 1913
页数:14
相关论文
共 37 条
  • [1] Structure and function of the blood-brain barrier
    Abbott, N. Joan
    Patabendige, Adjanie A. K.
    Dolman, Diana E. M.
    Yusof, Siti R.
    Begley, David J.
    [J]. NEUROBIOLOGY OF DISEASE, 2010, 37 (01) : 13 - 25
  • [2] Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer
    Abu Samaan, Tala M.
    Samec, Marek
    Liskova, Alena
    Kubatka, Peter
    Busselberg, Dietrich
    [J]. BIOMOLECULES, 2019, 9 (12)
  • [3] Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
    Ahles, Tim A.
    Root, James C.
    Ryan, Elizabeth L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30) : 3675 - 3686
  • [4] Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on β-structure in the core domain
    Barghorn, S
    Davies, P
    Mandelkow, E
    [J]. BIOCHEMISTRY, 2004, 43 (06) : 1694 - 1703
  • [5] Cognitive function in breast cancer patients receiving adjuvant chemotherapy
    Brezden, CB
    Phillips, KA
    Abdolell, M
    Bunston, T
    Tannock, IF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2695 - 2701
  • [6] Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases
    Brkic, Marjana
    Balusu, Sriram
    Libert, Claude
    Vandenbroucke, Roosmarijn E.
    [J]. MEDIATORS OF INFLAMMATION, 2015, 2015
  • [7] Buée L, 1999, BRAIN PATHOL, V9, P681
  • [8] Accurate segmentation of prostate cancer histomorphometric features using a weakly supervised convolutional neural network
    Bukowy, John David
    Foss, Halle
    McGarry, Sean D.
    Lowman, Allison
    Hurrell, Sarah
    Ickzkowski, Kenneth A.
    Banerjee, Anjishnu
    Bobholz, Samuel A.
    Barrington, Alexander
    Dayton, Alex
    Unteriner, Jackson
    Jacobsohn, Kenneth
    See, William
    Nevalanian, Marja
    Nencka, Andrew
    Ethridge, Tyler
    Jarrard, David
    LaViolette, Peter
    [J]. JOURNAL OF MEDICAL IMAGING, 2020, 7 (05)
  • [9] Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment
    Chiang, Angie C. A.
    Huo, Xiaojiao
    Kavelaars, Annemieke
    Heijnen, Cobi J.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2019, 79 : 319 - 325
  • [10] The prognostic value of theTau protein serum level in metastatic breast cancer patients and its correlation with brain metastases
    Darlix, Amelie
    Hirtz, Christophe
    Thezenas, Simon
    Maceski, Aleksandra
    Gabelle, Audrey
    Lopez-Crapez, Evelyne
    De Forges, Helene
    Firmin, Nelly
    Guiu, Severine
    Jacot, William
    Lehmann, Sylvain
    [J]. BMC CANCER, 2019, 19 (1)